Background: Desmoplastic small round cell tumor (DSRCT) is a distinctive clinicopathologic entity with an aggressive clinical course that typically involves the abdominal and/or pelvic peritoneum of young males. A population of small round blue cells and a fibroesclerotic stroma are the usual morphologic features. This tumor is characterized by a typical polyphenotypic profile with expression of epithelial, mesenchymal and neural markers. Cytogenetically, this tumor presents a unique abnormality – t(11;22)(p13;q12). Case: A 29-year-old male without significant medical history was admitted to our institution with gastrointestinal symptomatology. The physical examination and medical imaging studies revealed an extensive soft tissue mass filling the entire peritoneal cavity/pelvis. A fine-needle aspiration (FNA) of the abdominal mass was performed. The FNA smears revealed fragments of collagenous desmoplastic stroma and clusters of loosely cohesive small round cells that showed positivity for epithelial and myogenic markers. Cytogenetic analysis demonstrated rearrangement of the genes EWSR1 and WT1, resulting from the t(11;22)(p13;q12). Conclusion: DSRCT is an uncommon neoplasm that shares clinical and cytomorphologic features with other small round cell tumors. Therefore, a primary definitive diagnosis based on cytology specimens may be difficult but plausible and can be aided by a typical clinical presentation and ancillary immunocytochemical/cytogenetic studies.

1.
Gerald WL, Rosai J: Case 2: Desmoplastic small round cell tumor with divergent differentiation. Pediatr Pathol 1989;9:177–183.
2.
Gerald WL, Miller HK, Battifora H et al: Intra-abdominal desmoplastic small round-cell tumor: report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 1991;15:499–513.
3.
Fletcher CD, Unni KK, Mertens F (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, IARC, 2002, pp 216–218.
4.
Chang F: Desmoplastic small round cell tumors: cytologic, histologic and immunohistochemical features. Arch Pathol Lab Med 2006;130:728–732.
5.
Qian X: Soft tissue; in Cibas ES, Ducatman BS (eds): Cytology: Diagnostic Principles and Clinical Correlates, ed 3. Philadelphia, Elsevier, 2008, pp 479.
6.
Crapanzano JP, Cardillo M, Lin O, Zakowski MF: Cytology of desmoplastic small round cell tumor: a series including findings in ThinPrep. Cancer 2002;96:21–31.
7.
Granja NM, Begnami MD, Bortolan J, Filho AL, Schmitt FC: Desmoplastic small round cell tumour: cytological and immunocytochemical features. Cytojournal 2005;2:6.
8.
Ferlicot S, Coué O, Gilbert E, Beuzeboc P, Servois V, Klijanienko J, Delattre O, Vielh P: Intraabdominal desmoplastic small round cell tumor: report of a case with fine needle aspiration, cytologic diagnosis and molecular confirmation. Acta Cytol 2001;45:617–621.
9.
Waugh MS, Dash RC, Turner KC, Dodd LG: Desmoplastic small round cell tumor: using FISH as an ancillary technique to support cytologic diagnosis in an unusual case. Diagn Cytopathol 2007;35:516–520.
10.
Amato RJ, Ellerhorst JA, Ayala AG: Intraabdominal desmoplastic small round cell tumor: report and discussion of five cases. Cancer 1996;78:845–851.
11.
Gerald WL, Ladanyi M, de Alava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, Rosai J: Clinical, pathologic and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol 1998;16:3028–3036.
12.
Hill DA, Pfeifer JD, Marley EF, et al: WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor: immunohistochemical and molecular diagnostic study. Am J Clin Pathol 2000;114:345–353.
13.
Gerald WL, Rosai J, Ladanyi M: Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci USA 1995;92:1028–1032.
14.
Ladanyi M, Gerald WL: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 1994;54:2837–2840.
15.
Lae ME, Roche PC, Jin L, Lloyd RV, Nascimento AG: Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical and molecular study of 32 tumors. Am J Surg Pathol 2002;26:823–835.
16.
Fletcher CDM (ed): Diagnostic Histopathology of Tumors, ed 3. Philadelphia, Churchill Livingstone, 2007, vol 1, pp 889–891.
17.
Bian Y, Jordan AG, Rupp M, Cohn H, McLaughlin CJ, Miettinen M: Effusion cytology of desmoplastic small round cell tumor of the pleura: a case report. Acta Cytol 1993;37:77–82.
18.
Choi JK, van Hoeven K, Brooks JJ, Gupta PK: Desmoplastic small round cell tumor presenting in pleural fluids and accompanied by desmin-positive mesothelial cells. Acta Cytol 1995;39:377–378.
19.
Akhtar M, Ali MA, Sabbah R, Bakry M, al-Dayel F: Small round cell tumor with divergent differentiation: cytologic, histologic and ultrastructural findings. Diagn Cytopathol 1994;11:59–64.
20.
Dave B, Shet T, Chinoy R: Desmoplastic round cell tumor of childhood: can cytology with immunocytochemistry serve as an alternative for tissue diagnosis? Diagn Cytopathol 2005;32:330–335.
21.
Das DK, Bhambhani S, Chachra KL, Murthy NS, Tripathi RP: Small round cell tumours of the abdomen and thorax: role of fine needle aspiration cytologic features in the diagnosis and differential diagnosis. Acta Cytol 1997;41:1035–1047.
22.
Zeppa P, Lepore M, Vetrani A, Palombini L: Occult lymph node metastasis from desmoplastic small round cell tumor diagnosed by fine needle aspiration cytology: a case report. Acta Cytol 2003;47:501–505.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.